Antiprotozoals: Nursing pharmacology

Antiprotozoals: Nursing pharmacology

Nursing Pharmacology

Nursing Pharmacology

Pharmacodynamics: Nursing pharmacology
Pharmacokinetics - Absorption: Nursing pharmacology
Pharmacokinetics - Distribution: Nursing pharmacology
Pharmacokinetics - Metabolism: Nursing pharmacology
Pharmacokinetics - Elimination: Nursing pharmacology
Anthelmintics: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Antibiotics - Antimycobacterials: Nursing pharmacology
Antibiotics - Beta lactam and beta lactamase inhibitor combinations: Nursing pharmacology
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Antimalarials: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Chloramphenicol: Nursing pharmacology
Medications for respiratory syncytial virus (RSV): Nursing pharmacology
Neonatal eye prophylaxis: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Nitrates: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Insulin: Nursing pharmacology
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology

Notes

ANTIPROTOZOALS
DRUG NAME
atovaquone (Mepron), tinidazole (Tindamax), pyrimethamine (Daraprim), benznidazole (Rochagan, Radanil), nitazoxanide, pentamidine (NebuPent)
CLASS
Antiprotozoals
MECHANISM OF ACTION
Block DNA synthesis in protozoa → prevent reproduction → death
INDICATIONS
Protozoan infections (e.g., giardiasis, trichomoniasis, intestinal amebiasis)
ROUTE(S) OF ADMINISTRATION
  • PO (atovaquone, tinidazole, pyrimethamine, benznidazole, nitazoxanide)
  • IV (pentamidine)
  • IM (pentamidine)
  • INH - nebulizer (pentamidine)
SIDE EFFECTS
  • Headaches, dizziness, peripheral neuropathy, ataxia, loss of coordination
  • Skin rash, urticaria
  • Gastrointestinal disturbances (e.g., unpleasant mouth taste, nausea, vomiting, diarrhea, cramping)
  • Disrupt intestinal flora → bacterial or fungal superinfections
  • Hematologic abnormalities (e.g., leukopenia, anemia, thrombocytopenia)
  • Tinidazole: Boxed warning: malignancy
CONTRAINDICATIONS AND CAUTIONS
  • Pregnancy and breastfeeding
  • Children and elderly clients
  • Hematologic disorders
  • Central nervous system disorders
  • Cardiac, hepatic, or renal disease
  • Alcohol use
NURSING CONSIDERATIONS: ANTIPROTOZOALS
ASSESSMENT AND MONITORING
Assessment
  • Symptoms of infection; e.g., fatigue, stomach pain and cramping, stool characteristics and frequency, signs of dehydration
  • Laboratory test results: liver function tests, stool culture, DFA

Monitoring
  • Stool culture results
  • Side effects
  • Therapeutic effect of infection resolution
CLIENT EDUCATION
  • Purpose of medication: helps resolve their infection and shorten contagious time
  • Take medication once daily with food
  • Avoid alcohol during treatment and for three days after treatment is complete
  • Common side effects; e.g., headaches, unpleasant taste
  • Notify healthcare provider:
    • Dizziness, peripheral neuropathy
    • Signs of superinfection
  • Resolution of infection takes a few weeks
    • Stool is infectious until they receive a negative stool culture result
    • Precautions to avoid infecting others
      • Wash their hands with soap and water frequently; after using the bathroom; before preparing food or eating
      • Avoid swimming in pools, hot tubs, lakes, rivers, and the ocean until one week after the tinidazole course is complete
  • Prevention of future infections
    • Avoid swallowing water from swimming pools, hot tubs and splash pads
    • Pretreat drinking water when camping or traveling
Author: Antonia Syrnioti, MD
Author: Ashley Mauldin, MSN, APRN, FNP-BC
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antiprotozoals are a group of medications used to treat protozoal infections, such as giardiasis, trichomoniasis, or intestinal amebiasis.

The most commonly used antiprotozoals are atovaquone, tinidazole, benznidazole, pyrimethamine, and nitazoxanide, which can be taken orally; as well as pentamidine that can be administered by nebulizer, intramuscularly, or intravenously.

Once administered, antiprotozoals act on protozoa by blocking DNA synthesis, preventing them from reproducing, and ultimately killing them.

Side effects typically include headaches, dizziness, peripheral neuropathy, ataxia, and loss of coordination. Some clients may also develop a skin rash or urticaria.

In addition, antiprotozoals may often cause gastrointestinal disturbances, such as an unpleasant mouth taste, nausea, vomiting, diarrhea, and cramping.

Moreover, these medications can disrupt the normal intestinal flora, so clients might develop bacterial or fungal superinfections.

Finally, some of these medications can be associated with hematologic abnormalities, such as leukopenia, anemia, or thrombocytopenia; while tinidazole has a boxed warning for increasing the risk of developing malignancy.

Now, antiprotozoals are contraindicated during pregnancy and breastfeeding, while precautions should be taken with children and elderly clients.

In addition, these medications should also be used with caution in clients with hematologic or central nervous system disorders, as well as in those with cardiac, renal, or hepatic disease, and alcoholic beverages should be avoided.

Okay, when caring for a client with giardiasis who has been prescribed tinidazole, first obtain a baseline of your client’s symptoms, such as fatigue, stomach pain and cramping, as well as stool characteristics and frequency.

Then, assess for signs of dehydration, such as decreased urine output, dark yellow urine, or decreased skin turgor.

Lastly, review their most recent laboratory test results, including liver function tests, as well as stool culture and microscopy with direct fluorescent antibody testing, or DFA results.

Now, before your client begins treatment with an antiprotozoal like tinidazole, explain how their medication will help to resolve the infection and shorten the time they’re contagious, and remind them that their symptoms may take a few weeks to resolve.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens" Infect Dis Clin North Am (2019)
  6. "Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain" Pathogens (2021)
  7. "A new effective antiplasmodial compound: Nanoformulated pyrimethamine" J Glob Antimicrob Resist (2020)
  8. "Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors" ACS Med Chem Lett (2021)